About Skymap
Skymap is a company based in Faridabad (India) founded in 2007 by K L Gupta. It operates as a CDMO and Out-Licensing. The company has 314 employees as of March 31, 2024. Skymap offers products and services including Dry Powder Injection, Liquid Injection, Eye/Ear Drops, Tablets, and Capsules. Skymap operates in a competitive market with competitors including Enzene Biosciences, Hybio Pharmaceutical, Suanfarma, Nephron Pharmaceuticals and AmbioPharm, among others.
- Headquarter Faridabad, India
- Employees 314 as on 31 Mar, 2024
- Founders K L Gupta
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Skymap Pharmaceuticals Pvt. Ltd.
- Jurisdiction New Delhi, Delhi, India
-
Annual Revenue
$46.83 M (USD)13.68as on Mar 31, 2024
-
Net Profit
$3.11 M (USD)2362.04as on Mar 31, 2024
-
EBITDA
$5.23 M (USD)78.6as on Mar 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
314
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Skymap
Skymap offers a comprehensive portfolio of products and services, including Dry Powder Injection, Liquid Injection, Eye/Ear Drops, Tablets, and Capsules.
Powder form medication for injection with annual production capacity.
Liquid medications for injection in ampoules or vials.
Solutions for eye and ear care in three-piece packaging.
Solid oral medications for various health treatments.
Encapsulated medications for internal use.
Cream-based products for external skin applications.
Liquid formulations for skin care and treatment.
Oral solutions for consumption in measured doses.
Funding Insights of Skymap
Detailed funding history for Skymap
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Skymap
Investment portfolio details for Skymap
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Skymap
Detailed financials for Skymap
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Skymap Comparisons
Peer comparison for Skymap
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Skymap
Skymap operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Enzene Biosciences, Hybio Pharmaceutical, Suanfarma, Nephron Pharmaceuticals and AmbioPharm, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Company specializing in development of Biosimilars
|
|
| Locked | Locked | Locked |
Polypeptide drugs and APIs are developed and manufactured.
|
|
| Locked | Locked | Locked |
Generics, nutraceuticals, and APIs are developed by Suanfarma.
|
|
| Locked | Locked | Locked |
Sterile pharmaceutical products are manufactured and contract services are provided.
|
|
| Locked | Locked | Locked |
CDMO and analytical services for peptide development are provided.
|
|
| Locked | Locked | Locked |
APIs and finished dosage forms are developed and manufactured.
|
Detailed competitors of Skymap
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Skymap
Complete news archive for Skymap
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Skymap
Skymap was founded in 2007.
Skymap is headquartered in Faridabad, India. It is registered at Faridabad, Haryana, India.
As of Mar 31, 2024, the latest employee count at Skymap is 314.
Annual revenue of Skymap is $46.83M as on Mar 31, 2024.
Skymap Pharmaceuticals, established in 2007, is a family-owned company specializing in manufacturing a wide range of pharmaceutical products such as sterile injectables, tablets, capsules, and ointments. They operate from facilities in Faridabad and Roorkee, India, emphasizing quality compliance and timely delivery. The company provides services like CDMO and out-licensing to global partners, focusing on innovation in drug production while adhering to international standards.
Skymap's top competitors include Nephron Pharmaceuticals, Suanfarma and Enzene Biosciences.
Skymap offers Dry Powder Injection, Liquid Injection, Eye/Ear Drops, Tablets, and 4 more products and services.